PHIO:NASDAQ
Phio Pharmaceuticals Corp
$1.00
0.00%
(0.00) 1D
$1.01
arrow_upward
+1.00% (+0.0100)todayPre-market
Closed: Sep 22, 4:00:01 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for PHIO...
Mkt. cap
11.62M
Avg. vol.
169.30K
Volume
220.00
52-wk high
$4.19
52-wk low
$0.81
EPS
-$1.39
Beta
0.80
Shares outstanding
11.62M
No. of employees
6
Mkt. cap
11.62M
Avg. vol.
169.30K
Volume
220.00
52-wk high
$4.19
52-wk low
$0.81
EPS
-$1.39
Beta
0.80
Shares outstanding
11.62M
No. of employees
6
News stories
From web sources and news partners
Profile
Phio Pharmaceuticals Corporation is a US clinical stage biotechnology company developing its INTASYL siRNA in immuno-oncology. Formerly known as RXi Pharmaceuticals, the company's name was changed to Phio Pharmaceuticals in 2018. Wikipedia
About Phio Pharmaceuticals Corp